ClinicalTrials.Veeva

Menu

Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)

Columbia University logo

Columbia University

Status and phase

Completed
Phase 4

Conditions

Post Operative Pain

Treatments

Drug: Hydromorphone PCA
Drug: Morphine PCA

Study type

Interventional

Funder types

Other

Identifiers

NCT00385541
AAAA2949

Details and patient eligibility

About

Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug

Enrollment

50 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients scheduled for abdominal surgery requiring post-operative PCA
  • ASA = I or II

Exclusion criteria

  • preoperative pain or use of pain medication
  • narcotic allergy
  • morbid obesity (Body Mass Index > 30)
  • diagnosis of sleep apnea
  • hepatic or renal disease
  • use of medications that would affect narcotic pharmacodynamics
  • preoperative nausea, vomiting, or pruritis
  • diagnosis of alcoholism

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

50 participants in 2 patient groups

A
Active Comparator group
Description:
Patients receive morphine 1mg/dose PCA for postsurgical pain; max 10 mg/hr; lockout 6 minutes.
Treatment:
Drug: Morphine PCA
B
Active Comparator group
Description:
Patients receive hydromorphone 0.2mg/dose PCA for postsurgical pain; max 10mg/hr; lockout 6 minutes.
Treatment:
Drug: Hydromorphone PCA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems